What is the equivalent dose of Wellbutrin (bupropion) for a patient taking 10mg of Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bupropion Equivalent Dosing for 10mg Escitalopram

The equivalent dose of Wellbutrin (bupropion) for a patient taking 10mg of Lexapro (escitalopram) is approximately 175-200mg daily of bupropion SR (sustained release). 1

Dosing Considerations

  • Bupropion SR is typically started at 150mg once daily for 3 days, then increased to 150mg twice daily (300mg total daily dose) for depression treatment 2
  • For patients transitioning from escitalopram 10mg, starting with 150mg daily of bupropion SR and titrating based on response is appropriate 2, 1
  • The dose equivalence research indicates that bupropion 348.5mg is equivalent to fluoxetine 40mg, which would make approximately 175-200mg of bupropion roughly equivalent to escitalopram 10mg in antidepressant effect 1

Formulation Differences

  • Bupropion is available in multiple formulations:
    • Immediate Release (IR): Maximum dose 450mg/day
    • Sustained Release (SR): Maximum dose 400mg/day
    • Extended Release (XL): Maximum dose 450mg/day 2
  • For most patients, the SR formulation dosed at 150mg twice daily provides optimal therapeutic effect with manageable side effects 2

Titration Schedule

  • Begin with 150mg once daily of bupropion SR for the first 3-7 days 3, 2
  • If well tolerated, increase to 150mg twice daily (300mg total) 2
  • To minimize risk of insomnia, administer the second dose before 3 p.m. 3
  • Maximum recommended dose is 400mg daily for SR formulation 2

Special Population Considerations

  • For older adults: Start with 37.5mg every morning, then increase by 37.5mg every 3 days as tolerated 3
  • For patients with moderate to severe hepatic impairment: Total daily dose should not exceed 150mg daily 2
  • For patients with moderate to severe renal impairment: Total daily dose should be reduced by half 2

Safety Considerations

  • Bupropion should be avoided in patients with:
    • Seizure disorders (lowers seizure threshold)
    • Patients taking MAOIs or within 14 days of discontinuing MAOIs
    • Uncontrolled hypertension 2
  • Common side effects include:
    • Agitation, dry mouth, insomnia, headaches, nausea, constipation, and tremor 4
    • Activating effects (increased energy, reduced apathy) 3

Monitoring

  • Assess for neuropsychiatric adverse effects, especially in individuals younger than 24 years 2
  • Monitor vital signs, particularly blood pressure 2
  • Efficacy should be evaluated after 4-6 weeks of treatment at therapeutic dose 4
  • If no response is seen after 6-8 weeks at an adequate dose, consider alternative treatment 2

Clinical Advantages of Bupropion

  • Bupropion is the only antidepressant with no appreciable activity on serotonin concentrations, acting primarily on norepinephrine and dopamine neurotransmitters 4
  • May be particularly beneficial for patients with depression who also want to quit smoking 2
  • Generally causes less sexual dysfunction and weight gain than SSRIs like escitalopram 4

Combination Therapy Considerations

  • If considering combination therapy rather than switching, studies show that escitalopram 10mg plus bupropion SR (mean dose 327mg/day) resulted in 50% remission rates, which is higher than typical SSRI monotherapy 5
  • The combination was well-tolerated with only 6% discontinuation due to side effects 5

References

Guideline

Bupropion Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Other Antidepressants.

Handbook of experimental pharmacology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.